Supernus Pharm (SUPN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SUPN | TEVA | BBIO | RDY | BHC |
| Company | Supernus Pharm | Teva Pharmaceutical Industries ADR | Bridgebio Pharma Inc | Dr. Reddy's Laboratories Ltd ADR | Bausch Health Companies Inc |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NYSE | NYSE |
| Open | 49.81 | 28.77 | 70.22 | 13.63 | 5.10 |
| High | 51.94 | 29.64 | 74.65 | 13.91 | 5.41 |
| Low | 49.65 | 28.71 | 70.22 | 13.62 | 5.10 |
| Latest | 51.74 | 29.70 | 74.57 | 13.78 | 5.38 |
| Change | +2.39 | +1.35 | +5.21 | +0.32 | +0.35 |
| % Change | +4.84% | +4.76% | +7.51% | +2.38% | +6.96% |
| Volume | 197,494 | 3,122,450 | 1,211,365 | 1,248,054 | 1,100,184 |
| 20-Day Average Volume | 622,932 | 7,663,669 | 1,997,894 | 2,246,611 | 1,664,620 |
| Previous Close | 49.35 | 28.35 | 69.36 | 13.46 | 5.03 |
| Industry | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 51.10 | 29.91 | 69.65 | 14.02 | 5.19 |
| 20-Day Raw Stochastic | 49.79% | 25.42% | 86.20% | 31.45% | 52.98% |
| 20-Day Relative Strength | 52.18 | 43.65 | 55.24 | 46.33 | 46.44 |
| Weighted Alpha | +53.27 | +101.61 | +117.39 | +5.74 | -24.26 |
| Today's Opinion | 88% Buy | 8% Buy | 48% Buy | 72% Sell | 88% Sell |
| Previous Opinion | 40% Buy | 8% Buy | 8% Buy | 56% Sell | 100% Sell |
| Last Month's Opinion | 100% Buy | 80% Buy | 24% Buy | 32% Buy | 48% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +4.58% since 03/24/26 | +1.44% since 03/24/26 | +8.29% since 03/24/26 | +2.30% since 03/24/26 | +7.72% since 03/24/26 |
| Low | 48.85 on 03/30/26 | 28.28 on 03/30/26 | 68.83 on 03/30/26 | 13.37 on 03/30/26 | 4.99 on 03/27/26 |
| High | 51.89 on 03/31/26 | 30.42 on 03/25/26 | 74.43 on 03/31/26 | 13.97 on 03/25/26 | 5.39 on 03/31/26 |
| 1-Month | |||||
| %Chg | -5.65% since 02/27/26 | -12.70% since 02/27/26 | +11.63% since 02/27/26 | -4.31% since 02/27/26 | -9.36% since 02/27/26 |
| Low | 46.83 on 03/20/26 | 28.28 on 03/30/26 | 62.77 on 03/03/26 | 13.37 on 03/30/26 | 4.93 on 03/24/26 |
| High | 56.49 on 03/04/26 | 34.20 on 03/02/26 | 75.90 on 03/10/26 | 14.61 on 03/10/26 | 6.00 on 03/02/26 |
| 3-Month | |||||
| %Chg | +0.14% since 12/26/25 | -7.31% since 12/26/25 | -2.10% since 12/26/25 | -2.82% since 12/26/25 | -25.35% since 12/26/25 |
| Low | 46.83 on 03/20/26 | 28.28 on 03/30/26 | 62.77 on 03/03/26 | 12.81 on 01/20/26 | 4.93 on 03/24/26 |
| High | 59.68 on 02/25/26 | 37.35 on 02/03/26 | 84.94 on 02/12/26 | 14.80 on 02/25/26 | 8.00 on 01/07/26 |
| 6-Month | |||||
| %Chg | +9.80% since 09/26/25 | +61.18% since 09/26/25 | +48.27% since 09/26/25 | -3.23% since 09/26/25 | -17.05% since 09/26/25 |
| Low | 43.11 on 11/05/25 | 18.47 on 09/29/25 | 50.50 on 09/29/25 | 12.81 on 01/20/26 | 4.93 on 03/24/26 |
| High | 59.68 on 02/25/26 | 37.35 on 02/03/26 | 84.94 on 02/12/26 | 14.95 on 10/22/25 | 8.00 on 01/07/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 2,841,672 | 32,597,198 | 13,446,339 | 11,234,174 | 1,874,068 |
| Shares Outstanding, K | 57,582 | 1,149,813 | 193,863 | 834,634 | 372,578 |
| Annual Sales | 718,950,000 | 17,258,000,000 | 502,080,000 | 3,811,000,000 | 10,266,000,000 |
| Annual Net Income | -38,550,000 | 1,411,000,000 | -724,930,000 | 663,000,000 | 157,000,000 |
| Last Quarter Sales | 211,570,000 | 4,711,000,000 | 154,180,000 | 977,400,000 | 2,796,000,000 |
| Last Quarter Net Income | -4,110,000 | 481,000,000 | -192,860,000 | 135,500,000 | -112,000,000 |
| 60-Month Beta | 0.70 | 0.72 | 1.13 | 0.34 | 0.37 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.92 on 02/24/26 | 0.96 on 01/28/26 | -1.00 on 02/24/26 | 0.16 on 01/21/26 | 1.08 on 02/18/26 |
| Latest Earnings Date | 05/05/26 | 04/29/26 | 05/05/26 | 05/08/26 | 04/29/26 |
| Most Recent Dividend | N/A | 0.072 on 11/27/17 | N/A | 0.071 on 07/25/25 | 1.000 on 11/10/10 |
| Next Ex-Dividends Date | N/A | 11/27/17 | N/A | 07/25/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 21.82 | 10.23 | 0.00 | 17.51 | 1.35 |